...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Bowel morbidity following radiochemotherapy and image-guided adaptive brachytherapy for cervical cancer: Physician- and patient reported outcome from the EMBRACE study
【24h】

Bowel morbidity following radiochemotherapy and image-guided adaptive brachytherapy for cervical cancer: Physician- and patient reported outcome from the EMBRACE study

机译:放射性化学疗法和宫颈癌的图像引导式适应性近距离放射治疗的肠发病率:医生和患者报告了拥抱研究的结果

获取原文
获取原文并翻译 | 示例
           

摘要

Background/Purpose: This study describes late bowel morbidity prospectively assessed in the multi-institutional EMBRACE study on MRI-guided adaptive brachytherapy in locally advanced cervical cancer (LACC).
机译:背景/目的:本研究描述了在局部晚期宫颈癌(LACC)的MRI引导适应性近距离放射治疗的多机构接受研究中预期评估的晚期肠病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号